|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/12 Opko Health, Inc. 10-Q 9/30/12 60:6.7M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 456K
2: EX-2.8 Plan of Acquisition, Reorganization, Arrangement, HTML 287K
Liquidation or Succession
3: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 18K
40: R1 Document and Entity Information HTML 38K
30: R2 Condensed Consolidated Balance Sheets HTML 134K
38: R3 Condensed Consolidated Balance Sheets HTML 60K
(Parenthetical) (Unaudited)
42: R4 Condensed Consolidated Statements of Operations HTML 116K
(Unaudited)
55: R5 Condensed Consolidated Statements of Comprehensive HTML 39K
Loss (Unaudited)
32: R6 Condensed Consolidated Statements of Cash Flows HTML 168K
(Unaudited)
37: R7 Business and Organization HTML 29K
27: R8 Summary of Significant Accounting Policies HTML 41K
18: R9 Loss Per Share HTML 24K
56: R10 Composition of Certain Financial Statement HTML 55K
Captions
44: R11 Acquisitions, Investments, and Licenses HTML 98K
43: R12 Discontinued Operations HTML 44K
48: R13 Fair Value Measurements HTML 86K
49: R14 Derivative Contracts HTML 43K
47: R15 Related Party Transactions HTML 40K
50: R16 Commitments and Contingencies HTML 26K
39: R17 Segments HTML 61K
41: R18 Subsequent Events HTML 23K
46: R19 Summary of Significant Accounting Policies HTML 100K
(Policies)
60: R20 Composition of Certain Financial Statement HTML 54K
Captions (Tables)
52: R21 Acquisitions, Investments, and Licenses (Tables) HTML 75K
34: R22 Discontinued Operations (Tables) HTML 39K
45: R23 Fair Value Measurements (Tables) HTML 85K
36: R24 Derivative Contracts (Tables) HTML 32K
15: R25 Segments (Tables) HTML 52K
53: R26 Summary of Significant Accounting Policies HTML 40K
(Details)
57: R27 Loss Per Share (Details) HTML 28K
23: R28 Composition of Certain Financial Statement HTML 115K
Captions (Details)
22: R29 Acquisitions, Investments, and Licenses (Details) HTML 70K
25: R30 Acquisitions, Investments, and Licenses (Details HTML 49K
1)
26: R31 Acquisitions, Investments, and Licenses (Details HTML 64K
2)
28: R32 Acquisitions, Investments, and Licenses (Details HTML 286K
Textual)
14: R33 Discontinued Operations (Details) HTML 34K
51: R34 Discontinued Operations (Details 1) HTML 34K
33: R35 Discontinued Operations (Details Textual) HTML 23K
35: R36 Fair Value Measurements (Details) HTML 41K
17: R37 Fair Value Measurements (Details 1) HTML 73K
59: R38 Fair Value Measurements (Details 2) HTML 41K
13: R39 Fair Value Measurements (Details Textual) HTML 38K
29: R40 Derivative Contracts (Details) HTML 33K
54: R41 Related Party Transactions (Details) HTML 239K
16: R42 Commitments and Contingencies (Details) HTML 33K
21: R43 Segments (Details) HTML 42K
24: R44 Segments (Details Textual) HTML 30K
31: R45 Subsequent Events (Details) HTML 34K
58: XML IDEA XML File -- Filing Summary XML 88K
20: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.03M
7: EX-101.INS XBRL Instance -- opk-20120930 XML 1.31M
9: EX-101.CAL XBRL Calculations -- opk-20120930_cal XML 186K
10: EX-101.DEF XBRL Definitions -- opk-20120930_def XML 592K
11: EX-101.LAB XBRL Labels -- opk-20120930_lab XML 1.25M
12: EX-101.PRE XBRL Presentations -- opk-20120930_pre XML 848K
8: EX-101.SCH XBRL Schema -- opk-20120930 XSD 187K
19: ZIP XBRL Zipped Folder -- 0001193125-12-463415-xbrl Zip 146K
| EX-32.2 |
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 73 of Title 18, United States Code)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant section 906 of the Sarbanes-Oxley Act of 2002, I, Juan F. Rodriguez, Chief Financial Officer of OPKO Health, Inc. (the “Company”), hereby certify that:
The Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2012 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 9, 2012
| Juan F. Rodriguez |
| Chief Financial Officer |
43
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/9/12 | 4 | ||
| For Period end: | 9/30/12 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/18/21 Opko Health, Inc. 10-K 12/31/20 111:16M |